Ovid Therapeutics Inc. (OVID) Social Stream
Ovid Therapeutics Inc (OVID) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Ovid Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 135 days, OVID's average price target has gone up $0.62.
Over the past 42 weeks, OVID's average upside potential has been 54.92%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
OVID Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 92 days, OVID's average broker recommendation rating improved by 0.3.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- OVID has a greater average analyst price target than 6.9% of all US stocks.
- OVID has a higher number of analysts covering the stock than 42.76% of all US stocks.
- In the context of stocks in the small market cap category, Ovid Therapeutics Inc's variance in analysts' estimates is lower than -48.42% of them.
- In the context of Pharmaceutical Products stocks, Ovid Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 51.72% of them.
Is OVID a Buy, Hold or Sell? See the POWR Ratings now!